Bright Peak Therapeutics

Bright Peak Therapeutics AG is a clinical-stage biotechnology company founded in 2018 and co-located in Allschwil, Switzerland (Switzerland Innovation Park Basel Area) and San Diego / Del Mar, California. The company engineers next-generation multi-functional immunotherapies for cancer and autoimmune disease, using a protein-engineering and site-specific chemical-conjugation platform to build multi-functional PD-1 inhibitors and cytokine immunoconjugates that combine novel and clinically validated mechanisms in a single molecule. Its lead program, BPT567, is a first-in-class PD1-IL18 immunoconjugate that entered a Phase 1/2a clinical trial. The company has raised a USD 90 million Series C led by Johnson & Johnson Innovation (JJDC) alongside Versant Ventures, RA Capital Management, Fidelity, Qatar Investment Authority, Invus, Venrock, KB Investment, Alexandria Venture Investments and Northleaf Capital Partners. Bright Peak is a therapeutics developer, not a software company: it publishes a corporate marketing site and no public developer program, API, SDK or machine-readable specification.

Bright Peak Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Immunotherapy, and Oncology.

🌐 Visit website 📡 Source on GitHub
11.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyTherapeuticsImmunotherapyOncologyLife SciencesPharmaceuticalsSwitzerland

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 11.1/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/bright-peak-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Bright Peak Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 3

The organization behind the API

Website
Website
 About
About
 LinkedIn
LinkedIn

Other 1

Properties that don't map to a standard resource type

SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: bright-peak-therapeutics
name: Bright Peak Therapeutics
description: 'Bright Peak Therapeutics AG is a clinical-stage biotechnology company founded in 2018 and co-located in Allschwil,
  Switzerland (Switzerland Innovation Park Basel Area) and San Diego / Del Mar, California. The company engineers next-generation
  multi-functional immunotherapies for cancer and autoimmune disease, using a protein-engineering and site-specific chemical-conjugation
  platform to build multi-functional PD-1 inhibitors and cytokine immunoconjugates that combine novel and clinically validated
  mechanisms in a single molecule. Its lead program, BPT567, is a first-in-class PD1-IL18 immunoconjugate that entered a Phase
  1/2a clinical trial. The company has raised a USD 90 million Series C led by Johnson & Johnson Innovation (JJDC) alongside
  Versant Ventures, RA Capital Management, Fidelity, Qatar Investment Authority, Invus, Venrock, KB Investment, Alexandria
  Venture Investments and Northleaf Capital Partners. Bright Peak is a therapeutics developer, not a software company: it
  publishes a corporate marketing site and no public developer program, API, SDK or machine-readable specification.'
image: https://brightpeaktx.com/wp-content/uploads/2021/03/brightpeak-logo.png
url: https://raw.githubusercontent.com/api-evangelist/bright-peak-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Biotechnology
- Therapeutics
- Immunotherapy
- Oncology
- Life Sciences
- Pharmaceuticals
- Switzerland
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://brightpeaktx.com/
- type: About
  url: https://brightpeaktx.com/about/
- type: Contact
  url: https://brightpeaktx.com/contact/
- type: PrivacyPolicy
  url: https://brightpeaktx.com/privacy-policy/
- type: TermsOfService
  url: https://brightpeaktx.com/terms-of-service/
- type: LinkedIn
  url: https://www.linkedin.com/company/bright-peak-therapeutics
- type: SecondaryMarket
  url: https://www.hiive.com/securities/bright-peak-therapeutics-stock
- type: DomainSecurity
  url: security/bright-peak-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/bright-peak-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-08'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Bright Peak Therapeutics is a clinical-stage biopharma whose product is a PD1-IL18 immunoconjugate, not software;
    brightpeaktx.com is a five-page WordPress marketing site (home, about, contact, privacy, terms) with no developer, docs,
    or API path at all.
  evidence:
  - url: https://brightpeaktx.com/openapi.json
    status: 404
  - url: https://brightpeaktx.com/llms.txt
    status: 404
  - url: https://brightpeaktx.com/.well-known/agent-card.json
    status: 404
  - url: https://brightpeaktx.com/developers
    status: 404
  - url: https://brightpeaktx.com/page-sitemap.xml
    status: 200
  checked: '2026-08-08'